Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
7.42
+0.05 (0.68%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Myriad Genetics Analyst Ratings
Total Analysts
16
Consensus Rating
Hold
Price Target
$20.17
Upside
+171.83%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +88.68% | Apr 17, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $24 → $20 | Buy | Maintains | $24 → $20 | +169.54% | Apr 1, 2025 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $12 → $13 | Hold → Buy | Upgrades | $12 → $13 | +68.46% | Mar 12, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $14 → $12 | Hold | Maintains | $14 → $12 | +54.99% | Mar 4, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $13 → $11 | Sell | Maintains | $13 → $11 | +48.25% | Mar 3, 2025 |
| Raymond James | Raymond James | Buy Reiterates $27 → $19 | Buy | Reiterates | $27 → $19 | +156.06% | Feb 25, 2025 |
| UBS | UBS | Hold Maintains $18 → $16 | Hold | Maintains | $18 → $16 | +115.63% | Feb 25, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +290.84% | Feb 12, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $24 → $14 | Hold | Maintains | $24 → $14 | +88.68% | Jan 30, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $29 → $18 | Strong Buy | Maintains | $29 → $18 | +142.59% | Jan 28, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +169.54% | Jan 16, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $15 → $13 | Sell | Maintains | $15 → $13 | +75.20% | Dec 13, 2024 |
| UBS | UBS | Hold Initiates $18 | Hold | Initiates | $18 | +142.59% | Dec 10, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $30 → $21 | Buy → Hold | Downgrades | $30 → $21 | +183.02% | Dec 9, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $32 → $21 | Hold | Maintains | $32 → $21 | +183.02% | Nov 18, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.